Literature DB >> 32060845

The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment.

Shi Yong Neo1, Andreas Lundqvist2.   

Abstract

Chemokines are soluble proteins that orchestrate cell migration in a regulated concentration gradient. During early stages of tumor development, chemokines shape the immune landscape of tumor microenvironment. CXCL9, also known as monokine induced by gamma-interferon (MIG), can be produced during inflammatory conditions by myeloid cells within the tumor microenvironment. It attracts cells expressing the CXCR3 receptor including activated T and NK cells and has been shown to play a role in responses to immune checkpoint therapy. Overexpression of CXCL9 has also shown to reduce tumor progression and metastasis via the inhibition of angiogenesis. Conversely, CXCL9 can act directly on tumor cells expressing the CXCR3 receptor to promote cell migration and epithelial mesenchymal transition. In this chapter we discuss the anti- and pro-tumoral features of CXCL9 within the tumor microenvironment.

Entities:  

Keywords:  Angiogenesis; Biomarker; CXC chemokines; CXCL9; CXCR3; Chemokines; Epithelial mesenchymal transition; Inflammation; MIG; Metastasis; Migration; NK cells; T cells; Tumor microenvironment; Tumors

Mesh:

Substances:

Year:  2020        PMID: 32060845     DOI: 10.1007/978-3-030-36667-4_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  11 in total

1.  Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial.

Authors:  Thomas Powles; Srikala S Sridhar; Yohann Loriot; Joaquim Bellmunt; Xinmeng Jasmine Mu; Keith A Ching; Jie Pu; Cora N Sternberg; Daniel P Petrylak; Rosa Tambaro; Louis M Dourthe; Carlos Alvarez-Fernandez; Maureen Aarts; Alessandra di Pietro; Petros Grivas; Craig B Davis
Journal:  Nat Med       Date:  2021-12-10       Impact factor: 53.440

2.  Biofabrication of 3D breast cancer models for dissecting the cytotoxic response of human T cells expressing engineered MAIT cell receptors.

Authors:  Madhuri Dey; Myong Hwan Kim; Momoka Nagamine; Ece Karhan; Lina Kozhaya; Mikail Dogan; Derya Unutmaz; Ibrahim T Ozbolat
Journal:  Biofabrication       Date:  2022-09-29       Impact factor: 11.061

Review 3.  Role of chemokine systems in cancer and inflammatory diseases.

Authors:  Hongyi Li; Min Wu; Xia Zhao
Journal:  MedComm (2020)       Date:  2022-06-08

Review 4.  Research trends in pharmacological modulation of tumor-associated macrophages.

Authors:  Neng Wang; Shengqi Wang; Xuan Wang; Yifeng Zheng; Bowen Yang; Juping Zhang; Bo Pan; Jianli Gao; Zhiyu Wang
Journal:  Clin Transl Med       Date:  2021-01

5.  Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers.

Authors:  Yufei Lv; Dongxu Lv; Xiaohong Lv; Ping Xing; Jianguo Zhang; Yafang Zhang
Journal:  Front Genet       Date:  2021-03-19       Impact factor: 4.599

Review 6.  TCR engineered T cells for solid tumor immunotherapy.

Authors:  Yikai Zhang; Zhipeng Liu; Wei Wei; Yangqiu Li
Journal:  Exp Hematol Oncol       Date:  2022-06-20

7.  Localized PD-1 Blockade in a Mouse Model of Renal Cell Carcinoma.

Authors:  Ngoc B Pham; Nevil Abraham; Ketki Y Velankar; Nathan R Schueller; Errol J Philip; Yasmeen Jaber; Ellen S Gawalt; Yong Fan; Sumanta K Pal; Wilson S Meng
Journal:  Front Drug Deliv       Date:  2022-05-09

8.  Large-scale bulk RNA-seq analysis defines immune evasion mechanism related to mast cell in gliomas.

Authors:  Rui Chen; Wantao Wu; Tao Liu; Yihan Zhao; Yifan Wang; Hao Zhang; Zeyu Wang; Ziyu Dai; Xiaoxi Zhou; Peng Luo; Jian Zhang; Zaoqu Liu; Li-Yang Zhang; Quan Cheng
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

9.  TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma.

Authors:  Vivian Changying Jiang; Dapeng Hao; Preetesh Jain; Yijing Li; Qingsong Cai; Yixin Yao; Lei Nie; Yang Liu; Jingling Jin; Wei Wang; Heng-Huan Lee; Yuxuan Che; Enyu Dai; Guangchun Han; Ruiping Wang; Kunal Rai; Andrew Futreal; Christopher Flowers; Linghua Wang; Michael Wang
Journal:  Mol Cancer       Date:  2022-09-26       Impact factor: 41.444

10.  Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.

Authors:  Zhuoyi Wu; Jinghai Wan; Jiawei Wang; Xiaoli Meng; Haipeng Qian
Journal:  Biochem Biophys Rep       Date:  2022-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.